CFDA dramatically increase registration fees for drug and clinical trials

China is a highly attractive clinical trial destination, and continues to see increased interest from CROs and drug development companies. China has a well-established tradition of developing medicines from basic research and the demands for modern pharmaceuticals is growing. Data gathered from indicated that in 2014, China had conducted 846 clinical trials, and an […]

Read More